Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

The scalp lotion helped increase hair thickness in cancer patients undergoing chemotherapy.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Chemotherapy and certain hair care practices can cause severe hair matting.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

PUVA-turban therapy can help some people with severe alopecia areata regrow hair.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

Radiotherapy is a good option when further surgery for skin cancer isn't preferred, but more research is needed to compare it with other methods.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Gefitinib therapy can cause unusual hair growth on the nose.

Tofacitinib helped a woman regrow hair with no major side effects.

Low-intensity ultrasound may help protect hair follicles from chemotherapy-induced hair loss.

Dutasteride may help shrink prostate cancer tumors.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

Panitumumab can cause excessive ear hair growth.